AFC-HD AMS Life Science Co., Ltd.

Equities

2927

JP3124700000

Food Processing

Delayed Japan Exchange 02:00:00 2024-07-18 am EDT 5-day change 1st Jan Change
920 JPY -0.54% Intraday chart for AFC-HD AMS Life Science Co., Ltd. +0.88% +15.00%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
AFC-HD AMS Life Science's Fiscal Nine-Month Attributable Profit Jumps 35% MT
Afc-Hd Ams Life Science Co., Ltd. Announces Dividend for the Second Quarter Ended February 2024, Payable on May 17, 2024 CI
Afc-Hd Ams Life Science Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ending February 2024 and Full Year Ending August 2024 CI
Afc-Hd Ams Life Science Co., Ltd. Announces Dividend for Year Ended August 2023, Payable on November 29, 2023; Provides Dividend Guidance for Year Ending August 2024 CI
AFC-HD AMS Life Science Co., Ltd. agreed to acquire Clarize Co., Ltd. from Toshiaki Fujita for ¥1 CI
AFC-HD AMS Life Science Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending August 31, 2023 CI
AFC-HD AMS Life Science Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending August 31, 2023 CI
Tranche Update on AFC-HD AMS Life Science Co., Ltd.'s Equity Buyback Plan announced on May 26, 2023. CI
AFC-HD AMS Life Science Co., Ltd.'s Equity Buyback announced on May 26, 2023, has closed with 100,000 shares, representing 0.71% for ¥79.57 million. CI
AFC-HD AMS Life Science Co., Ltd. announces an Equity Buyback for 100,000 shares, representing 0.71% for ¥100 million. CI
AFC-HD AMS Life Science Co., Ltd. authorizes a Buyback Plan. CI
AFC-HD AMS Life Science Co., Ltd. Announces Dividend for the Second Quarter Ended Feb. 2023, Payable on May 29, 2023 CI
AFC-HD AMS Life Science Co., Ltd. Provides Earnings Guidance for the Year Ending August 2023 CI
AFC-HD AMS Life Science Co., Ltd. Provides Dividend Guidance for the Year Ending August 2023 CI
AFC-HD AMS Life Science Co., Ltd. Provides Dividend Guidance for the Second Quarter and Full Year of Fiscal 2023 CI
AFC-HD AMS Life Science Co., Ltd. Provides Consolidated Earnings Guidance for the Period Ending February 2023 and August 2023 CI
AFC-HD AMS Life Science Co., Ltd. agreed to acquire a 51% stake in 5SPRO Joint Stock Company. CI
AFC-HD AMS Life Science Co., Ltd. Provides Consolidated Earnings Guidance for the Period Ending February 2023 and August 2023 CI
AFC-HD AMS Life Science Co., Ltd. Provides Dividend Guidance for the Second Quarter and Year End of Fiscal 2023 CI
AFC-HD AMS Life Science Co., Ltd. Announces Dividend for the Year End August 2022, Payable on November 30, 2022 CI
AFC-HD AMS Life Science Co., Ltd. Provides Consolidated Earnings Guidance for the Period Ending August 31, 2022 CI
AFC-HD AMS Life Science Co., Ltd. Provides Earnings Guidance for the Period Ending August 2022 CI
AFC-HD AMS Life Science Co., Ltd. Announces Dividend for the Second Quarter of 2022, Payable on May 16, 2022 CI
AFC-HD AMS Life Science Co., Ltd. Provides Dividend Guidance for the Year End August 2022 CI
AFC-HD AMS Life Science Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending August 2022 CI
Chart AFC-HD AMS Life Science Co., Ltd.
More charts
AFC-HD AMS Life Science Co Ltd is a Japan-based company mainly engaged in the development of the healthcare business and the pharmaceutical business. The Company is engaged in the research and development, product design, manufacture and sale of health foods and cosmetics, manufacture and sale of Chinese medicine medicines, general medicines, generic medicines, healthcare products, the sale of natural foods, as well as planning of health information programs. The Company operates in two business segments. The Healthcare segment is engaged in the manufacture and sale of health foods and cosmetics, as well as the provision of original equipment manufacturers (OEM). The Pharmaceutical segment is engaged in the manufacture and sale of ethical drugs and over-the-counter drugs, as well as the sale of generic drugs. The Company is also engaged in the management of restaurants through subsidiary.
More about the company
  1. Stock Market
  2. Equities
  3. 2927 Stock
  4. News AFC-HD AMS Life Science Co., Ltd.
  5. AFC-HD AMS Life Science's Fiscal Nine-Month Attributable Profit Jumps 35%